{"title": "Ascertainment rate of novel coronavirus disease (COVID-19) in Japan", "doi": "10.1101/2020.03.09.20033183", "citation_id": "2020.03.09.20033183v1", "date": "2020-03-10", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.09.20033183", "abstract": "<p>We analyzed the epidemiological dataset of confirmed cases with COVID-19 in Japan as of 28 February 2020 and estimated the number of severe and non-severe cases, accounting for under-ascertainment. The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval: 0.37, 0.50), indicating that unbiased number of non-cases would be more than twice the reported count. Severe cases are twice more likely diagnosed and reported than other cases.</p>", "twitter_description": "We analyzed the epidemiological dataset of confirmed cases with COVID-19 in Japan as of 28 February 2020 and estimated the number of severe and non-severe cases, accounting for under-ascertainment. The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval: 0.37, 0.50), indicating that unbiased number of non-cases would be more than twice the reported count. Severe cases are twice more likely diagnosed and reported than other cases.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nH.N. received funding support from Japan Agency for Medical Research and Development [grant number: JP18fk0108050] the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI in Japanese abbreviation) grant nos. 17H04701, 17H05808, 18H04895 and 19H01074, and the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) program [grant number: JPMJCR1413]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nThe data that support the findings of this study are available from the corresponding author upon reasonable request.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033183v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033183v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033183v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/10/2020.03.09.20033183.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.09.20033183v1", "access_rights": "restricted", "authors": ["Ryosuke Omori", "Kenji Mizumoto", "Hiroshi Nishiura"]}